How have SLGCW shares performed in 2023?

SomaLogic's stock was trading at $0.40 at the beginning of the year. Since then, SLGCW stock has decreased by 57.5% and is now trading at $0.17. View the best growth stocks for 2023 here .

Are investors shorting SomaLogic?

SomaLogic saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 1,800 shares, a drop of 21.7% from the October 31st total of 2,300 shares. Based on an average trading volume of 4,100 shares, the days-to-cover ratio is currently 0.4 days. View SomaLogic's Short Interest .

Who are SomaLogic's major shareholders?

SomaLogic's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of SomaLogic?

Shares of SLGCW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

SomaLogic Stock Price, News & Analysis (NASDAQ:SLGCW)

$0.17

0.00 (0.00%)

(As of 11/30/2023 ET)

Compare

Today's Range: $0.16
▼
$0.17
50-Day Range: $0.13
▼
$0.24
52-Week Range: $0.13
▼
$0.79

Volume: 1,484 shs
Average Volume: 5,340 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Headlines Ownership SEC Filings Short Interest Social Media

About SomaLogic Stock (NASDAQ:SLGCW)

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions. The company has a collaboration agreement with Illumina Cambridge, Ltd for the development of co-branded NGS-based proteomic distributable kits. The company was founded in 1999 and is headquartered in Boulder, Colorado.

SLGCW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SLGCW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive SLGCW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SomaLogic and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Information Services
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:SLGCW
CUSIP: N/A
CIK: 1837412
Web: www.somalogic.com
Phone: 303 625 9000
Fax: N/A
Employees: 451
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $81.72 million
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Dr. Stephen A. Williams BS (Age 63)
MB, Ph.D., Chief Medical Officer
Comp: $648.03k
Mr. Adam Taich (Age 48)
Interim CEO
Mr. Eliot M. Lurier CPA (Age 65)
Interim Chief Financial Officer
Mr. Pi Zheng (Age 50)
Interim Chief Accounting Officer
Dr. Jason Cleveland Ph.D.
Chief Technology Officer
Dr. Nebojsa Janjic Ph.D. (Age 62)
Chief Science Officer
Mr. Ruben Gutierrez J.D. (Age 48)
General Counsel
Ms. Alison Marie Roelke (Age 48)
Chief People Officer
Dr. Shane Bowen Ph.D.
Chief Research & Development Officer

Key Competitors

View All Competitors

SLGCW Stock Analysis - Frequently Asked Questions

How have SLGCW shares performed in 2023?: SomaLogic's stock was trading at $0.40 at the beginning of the year. Since then, SLGCW stock has decreased by 57.5% and is now trading at $0.17.
View the best growth stocks for 2023 here.
Are investors shorting SomaLogic?: SomaLogic saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 1,800 shares, a drop of 21.7% from the October 31st total of 2,300 shares. Based on an average trading volume of 4,100 shares, the days-to-cover ratio is currently 0.4 days.
View SomaLogic's Short Interest.
Who are SomaLogic's major shareholders?: SomaLogic's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%).
How do I buy shares of SomaLogic?: Shares of SLGCW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:SLGCW) was last updated on 12/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial